Skip to main content

CareFirst MVP Business Plan

The Care Wallet / Implant Passport Pilot — Oakland · Richmond · Tustin

Prepared from the requirements locked with Jim. Structure: Part I preserves the vision exactly as conceived, with its gaps mapped. Part II is a deliberately cold investor assessment. Part III answers the criticisms and refines the plan. Part IV is the verdict.

PART I — THE VISION, PRESERVED

1. The MVP in One Paragraph

CareFirst runs consumer advertisements for Care Wallet, centered on the Implant Passport promise — a lifetime guarantee of record-keeping for implant procedures and hassle-free aftercare for any implant placed — targeted at patients near three pilot offices: Raymond's offices in Oakland and Richmond, CA, and Dr. Charles Zahedi's office in Tustin, CA. Ads lead with full-arch reconstruction (with sleep apnea and dental aligners as possible later additions). Responding patients can schedule an appointment at a backing provider's office. Treating providers must store all treatment information — treatment planning, X-rays, diagnostics, everything — in the patient's Care Wallet, keeping the lifelong-record promise. Patients are free to get final treatment elsewhere, including overseas — particularly Qingdao, where Jim has strong dental-office connections that could support a medical-tourism pathway for full-arch cases. This bounded workflow is the proof of concept that the ecosystem can generate income.

2. The Workflow, End to End

  [1] ADS                [2] RESPONSE           [3] APPOINTMENT
  Care Wallet ads   →    Patient claims    →    Patient books at
  (Implant Passport      a Care Wallet,         Oakland / Richmond /
  promise; full-arch     enters funnel          Tustin office
  focus; geo-targeted)
                                                      │
                                                      ▼
  [6] AFTERCARE          [5] TREATMENT          [4] DIAGNOSTICS
  Lifelong record;  ←    Option A: treat   ←    Provider performs
  hassle-free            at pilot office        workup; ALL records
  maintenance at         Option B: treat        (planning, X-rays,
  any provider           overseas (Qingdao)     CBCT, diagnostics)
  reading the Wallet     with records via       written to Care Wallet
                         the Wallet

3. What Makes This the Right Bounded Workflow

Judged against the long-term vision, this MVP is well chosen in several ways:

  • It exercises the entire thesis in miniature. Patient acquisition → wallet creation → provider record-writing → optional cross-border continuity → lifelong aftercare. Every layer of the eventual ecosystem appears at small scale.
  • Full-arch is the correct wedge procedure. It is high-value (patients routinely pay $20k–$60k+ per arch domestically), record-intensive (CBCT, photogrammetry, prosthetic specs — exactly what the Passport is for), maintenance-dependent for decades (the aftercare promise has real teeth), and the procedure with the strongest overseas price arbitrage (making the Qingdao option genuinely attractive rather than theoretical).
  • The "treat anywhere" freedom is the differentiator, not a leak. A patient who takes their CareFirst records to Qingdao and comes back for aftercare is not a lost customer — they are the proof of the portability thesis. No competing clinic-marketing product can say that.
  • Three offices is honest scope. Small enough to run manually, large enough to generate a real conversion funnel.

4. The Acknowledged Ambiguities (as raised)

  1. Revenue mechanics are open. How the money is made is explicitly up for debate. 2. Scheduling — how patients get booked directly into providers' systems. 3. Fee capture — how CareFirst ensures it collects fees "for each patient that we refer." 4. Large-file storage — 3D CT scans and similar heavyweight imaging. 5. China / Great Firewall — how Care Wallet functions for the Qingdao pathway.

5. Additional Gaps in the Workflow (surfaced during drafting — assumptions used)

#GapAssumption used until answered
ACommitment status of the three offices (signed? verbal? prospective?) and Raymond's exact relationship to CareFirstAssumed: verbally committed, not contracted; Raymond assumed friendly/insider-adjacent
BWho funds the ad spendAssumed: CareFirst fronts it
CWhether "fee per referred patient" is the intended model or placeholder languageTreated as placeholder; see Part II §3 for why it cannot be the model as stated
DWhat backs the "lifetime guarantee"Assumed: nothing yet — marketing language only
EWhether CareFirst arranges Qingdao treatment or merely carries records for itBoth modeled; they are legally very different (Part II §5)
FWho does the patient-facing coordination labor (answering ad responses, scheduling, follow-up)Assumed: a human coordinator (Jim/team), not software, for the MVP
GWhat the patient pays, if anythingAssumed: wallet free to patient during pilot

PART II — THE INVESTOR'S ASSESSMENT

Written as a disinterested investor who has seen many healthcare marketplaces pitch. Blunt by design.

1. The One-Line Reaction

"You've described a customer-acquisition funnel with no legal way to get paid, wrapped around a promise you cannot currently keep ('lifetime'), sold under two names you likely can't use (CareFirst, Care Wallet), with the hardest version of the hardest market (cross-border China healthcare) attached to v1. The underlying asset — patient-portable implant records — is genuinely interesting. Everything around it needs surgery."

2. What I Like (credit where due)

  • Real pain, real wedge. Implant record loss is a genuine, documented clinical problem; full-arch patients are the ones who feel it most and pay the most. The "no implant should become unidentified" framing is memorable and true. - Founder-market fit. Warm relationships with the pilot offices and Qingdao providers substitute for capital in the earliest phase. Most marketplaces have to buy both sides; you appear to have both sides on friendly terms. - The portability differentiator is defensible. "Your records work even if you leave" is a promise incumbents structurally cannot make — practice-management vendors serve the office, not the patient. - Bounded scope discipline. Three offices, one procedure, one metric (income generated) — the right shape for a proof of concept.

3. Fatal Flaw #1 — The Revenue Model As Stated Is Likely Illegal

The plan says CareFirst will collect "fees for each patient that we refer." In California, Business & Professions Code §650 prohibits licensed healthcare providers (dentists included) from paying or receiving any consideration for the referral of patients. Federal anti-kickback statutes add exposure the moment any federally funded patient (Medicare Advantage dental benefits, Denti-Cal) enters the funnel. Per-patient referral payments from providers to a marketer are the textbook fact pattern regulators pursue, and dental boards discipline the dentists too — meaning the model endangers your own supply side.

There is a well-trodden safe harbor: flat-fee advertising and administrative services at fair market value, independent of patient volume or treatment value. But that is a different business model than the one stated, with different unit economics (you can't scale revenue with case value). The plan cannot proceed to a term sheet with "per-referral fees" anywhere in it. Notably, your own prior strategy documents already contain the correct principle — service fees, never referral fees — and this MVP as stated violates it.

4. Fatal Flaw #2 — "Lifetime Guarantee" From a Pre-Revenue Startup

A company with no revenue, no entity finalized, and an MVP-stage product is advertising a lifetime guarantee of record-keeping. Three problems, ascending:

  1. You can't keep it. Most startups die. When this one pivots or fails, the guarantee becomes thousands of broken promises attached to people's medical hardware.
  2. It's actionable. "Guarantee" in consumer advertising creates express-warranty exposure; in healthcare advertising it invites FTC and state AG attention. "Hassle-free aftercare" additionally implies a clinical promise CareFirst — not a provider — cannot make.
  3. It's unnecessary. The honest version ("your records, portable for life, exportable at any time, in open formats") is nearly as compelling and infinitely more defensible.

5. Fatal Flaw #3 — The Qingdao Pathway Multiplies Risk for Zero MVP Revenue

If CareFirst merely carries records the patient chooses to share overseas — fine, that's the product working. But the moment CareFirst arranges overseas treatment (marketing it, booking it, taking margin), it becomes a medical tourism facilitator, which triggers: liability for overseas outcomes (the #1 killer of medical-tourism startups — one botched full-arch case with no US recourse), the unresolved question of who provides and pays for revision surgery, China's PIPL and cross-border health-data transfer rules, and the Great Firewall infrastructure problem — all attached to a pilot whose stated goal is just to prove income generation. And a hard product fact: China's PIPL treats health data as sensitive personal information with strict cross-border transfer requirements; serving a mainland-hosted Care Wallet requires a Chinese entity, an ICP license, and in-country hosting — a six-figure, multi-quarter infrastructure project smuggled into an MVP.

6. Serious (Non-Fatal) Problems

  • CAC will be brutal. Full-arch keywords are among the most expensive in all of dental advertising (clicks routinely $15–50+; patient acquisition costs for implant cases run $300–$1,500+ through agencies). Three geo-targeted locations means thin ad inventory. With no per-case revenue capture (see §3), the pilot may generate provider value it cannot bill for. - Chicken-and-egg on the promise. "Hassle-free aftercare at any provider reading the Wallet" requires a network of providers who read the Wallet. At MVP, that network is three offices. A patient who moves to Denver has a passport nobody accepts yet. - Scheduling into providers' systems is being over-thought as a software problem: PMS integrations (Dentrix, Eaglesoft) are months of work and require BAAs. But note what the question reveals — the team is instinctively reaching for infrastructure where a phone call suffices at n=3 offices. - Provider compliance burden. The plan requires providers to upload everything. Dental offices are notorious for not doing optional paperwork. What forces the upload to happen, and what happens to the promise when an office uploads half the record? - Storage is the least of your problems — flagging it as a top-five ambiguity suggests effort is being allocated to the tractable-technical rather than the existential-legal. A CBCT study is 100–600 MB; a thousand pilot patients' full imaging fits in a few terabytes of object storage for tens of dollars a month with lifecycle tiering. This is a solved problem. - Names. The prior trademark research stands: advertising consumer-facing services under "CareFirst" and "Care Wallet" — both conflicting with registered marks, one held by a $10B insurer that sells dental plans — is materially riskier than internal use. Running paid ads is the exact act that creates "use in commerce" and invites enforcement. - Diversification temptation. Sleep apnea and aligners in v1 ads would triple the message surface, halve the budget per procedure, and blur the Implant Passport story. The passport concept doesn't even apply cleanly to aligners. - HIPAA posture. The moment a patient books through you and a provider writes records into your system, CareFirst is handling PHI at minimum as a conduit and almost certainly as a business associate of the pilot offices. BAAs with all three offices are a day-one requirement, not a post-pilot one — this MVP crosses the line the previous strategy deliberately stayed behind.

7. The Question I'd Ask at the Partner Meeting

"If the pilot works perfectly — ads convert, wallets fill, one patient even goes to Qingdao and comes back — what number goes up, and who paid it to you? Right now the honest answer is 'we're not sure, possibly nobody, legally.' Come back when that sentence has a number in it."

PART III — ANSWERING THE CRITICISMS

1. Fixing the Revenue Model (the central repair)

Replace per-referral fees with a stack of volume-independent, fair-market-value service fees — all fully compliant, all available now:

Layer 1 — Provider-side (the pilot's actual income):

  • Flat monthly marketing & administrative services fee per office (e.g., $2,000–$4,000/mo range, FMV-benchmarked against dental marketing agencies), covering ad management, the patient-intake concierge, and Care Wallet record infrastructure. Flat. Never per-patient, never per-case-value. This mirrors the already-designed $2,999 pilot structure from the marketing program — the model already exists in-house.
  • Optional: per-seat SaaS fee for Wallet access/tooling once the record product matures.

Layer 2 — Patient-side (small now, strategic later):

  • Care Wallet free during pilot; announce the intended $50–100/yr subscription so the future price is anchored, with pilot patients grandfathered as "founding members" — converting the lifetime-promise energy into a loyalty story instead of a warranty.
  • Flat coordination fee paid by the patient for cross-border case support (records preparation, translation, provider matching) — a patient-paid concierge service fee, not a provider kickback. This is the only compliant way to monetize the Qingdao pathway, and conveniently it's also the one where the customer (a patient saving $20k+ by going overseas) is least price-sensitive.

What this changes about the pilot's success metric: income = (3 offices × flat monthly fee) + (patient coordination fees). Modest, but legal, recurring, and provable — which is what a proof of concept must be.

Open question: will pilot providers actually pay the upfront fee?

A real concern, raised after drafting: offices may balk at paying a flat monthly fee to advertise full-arch cases that might not be treated in their chairs — leaving them "only collecting for a consultation and X-rays." The counter-economics are meaningful (most leads won't go overseas; one domestic full-arch conversion covers a year of fees; outbound patients return as lifetime maintenance annuities; diagnostics revenue itself approaches the fee at modest funnel volume), but whether that argument lands with the actual pilot offices is undecided and depends on the business model conversation Jim and Josh haven't finished.

One idea worth considering, though not strongly held: differentiate offices into diagnostic-node vs. treatment-center roles with different fee levels, and/or invert the trust direction with a free 60-day "Phase 0" that converts to paid fees only after CareFirst demonstrates booked-consult volume (backed by a signed conditional commitment letter). This trades faster income for a truthier proof point, but it presumes a tiering of providers that hasn't been agreed, and the whole question should stay open until the offices' actual in-house capabilities and appetites are known.

2. Fixing the Promise

Replace the guarantee with ownership language that is stronger because it's honest:

"Lifetime guarantee of record-keeping" → "Your implant records, complete and portable, for life — exportable by you, at any time, in standard formats, even if you never see us again."

Back it with a real mechanism instead of a warranty: every wallet supports full patient export (DICOM + PDF + structured data), and the pilot commits publicly that if CareFirst ever winds down, all patients receive their complete archive. That single design decision converts the fatal guarantee into the product's best feature: the promise is kept by architecture, not by the company's survival.

"Hassle-free aftercare" → "aftercare without the archaeology: any dentist you choose can see exactly what's in your mouth." Descriptive, true, no clinical warranty implied.

3. Fixing the Qingdao Pathway — "Records Travel First, Business Follows"

Sequence it in three gates, so the MVP gets the story without the liability:

  • Gate 1 (in the MVP): CareFirst is a records platform only for overseas care. A patient may authorize sharing with a Qingdao office; CareFirst provides export/translation support as a patient-paid service. CareFirst does not select, book, or take margin on overseas treatment. No China hosting: the patient-authorized share is delivered as a secure encrypted export / expiring link, which works through the firewall because it is the patient carrying their own data — sidestepping ICP licensing and mainland hosting entirely for now.
  • Gate 2 (post-MVP, if ≥3 patients complete the loop): formalize the Qingdao relationships as a credentialed receiving network with written responsibility allocation for complications and US aftercare — the two questions already flagged as unresolved in the master compendium.
  • Gate 3 (much later): a Chinese entity, PIPL-compliant in-country deployment, and a real two-sided cross-border product — only if Gates 1–2 prove demand.

4. Fixing the Remaining Mechanics

  • Scheduling: concierge model. Ads → CareFirst landing page → coordinator calls the patient within one business day → coordinator books directly with the office by phone/shared calendar. Zero PMS integration for the MVP. (This also is the fee-justifying administrative service in Layer 1.) - Provider upload compliance: make it structural, not aspirational — the coordinator runs a per-case checklist (CBCT ✓, treatment plan ✓, implant specs ✓, prosthetic details ✓) and the office's flat fee includes CareFirst staff doing the uploading for them from exported files. Never depend on office staff adopting new software in a pilot. - Storage: object storage (S3-class) with lifecycle tiering; DICOM kept in original format plus web-viewable derivatives. Budget line, not workstream. - Names: run pilot ads under a neutral campaign brand (even "Implant Passport pilot by [new name TBD]") while counsel clears or replaces CareFirst/Care Wallet. Do not create "use in commerce" on contested marks via paid advertising. Two candidate-screening rounds have been run; the surviving yellow-or-better shortlist to take to trademark counsel: Ankora 🟡 (clean in the US on preliminary search; flags: Ankora Health Nigeria, Ancora Health Netherlands, and phonetic neighbor Ankura Consulting), Arkiva 🟡 (no US health blocker; flags: international document-management/records users and UK infrastructure firm Arqiva), and First32 (the original name variant, preserved as a candidate; avoids the "Care" element entirely; not yet screened). Screened and dead: Dentity, Verident, Everdent, Aevum, Anya, Copal, Cairn, and the FirstCare reversal. - Ad scope: full-arch only. Sleep apnea and aligners are explicitly parked — revisit only after the full-arch funnel converts. - HIPAA: BAAs with all three offices signed before the first record is stored; minimum-necessary access; audit logging (already in the product's design DNA).

5. The Engineering Workstream — Invariant Work Only

While business-model, naming, and provider questions remain open, engineering proceeds only on work that is true in every surviving version of the company:

  1. Branding-config sweep — strip every hardcoded "CareFirst"/"Care Wallet" into a single config so the eventual rename is a config change, not a migration.
  2. The export engine — full-archive patient export (DICOM + PDF + structured JSON manifest), patient-triggered. This is simultaneously the product's core promise ("portable for life, even if we disappear"), the Qingdao Path A vehicle, and the wind-down commitment.
  3. The implant identity dataset — structured catalog of manufacturers → systems → platforms → connections → compatible components, keyed to public UDI data (AccessGUDID), starting with the systems the pilot and Qingdao offices actually place. The quiet moat.
  4. Consent/audit spine hardening — real authorization checks, immutable audit logging, tested revocation, encryption at rest: the HIPAA-readiness substrate BAAs will sit on.
  5. Record-completeness checklist engine — per-procedure-type completeness scoring for CareCases; powers the coordinator workflow and seeds the future internal evidence layer.
  6. Demo polish, DICOM/STL viewing, test harness — ongoing, safe, demo-ready regardless of open decisions.

Do-not-build fence (churn territory until decisions land): payments of any kind, PMS/scheduling integrations, anything $FIRST, China-side hosting, public Trust Scores, and further public marketing sites under the contested brand.

6. The Refined MVP on One Page

ElementAs statedAs refined
OfferingCare Wallet ads w/ lifetime guaranteeImplant Passport pilot: portable-for-life records, patient-exportable
ProceduresFull-arch, maybe apnea + alignersFull-arch only
OfficesOakland, Richmond, TustinSame
Patient cost(unstated)Free wallet; announced future subscription; grandfathered founders
Provider revenueFee per referred patient ⚠Flat monthly marketing + admin service fee (FMV)
Cross-border revenue(unstated; implied margin)Patient-paid flat coordination fee, records-only role
Qingdao mechanicsCare Wallet in ChinaEncrypted patient-authorized export; no China hosting
SchedulingDirect into provider systemsHuman concierge + phone/shared calendar
StorageOpen questionS3-class object storage; solved
Success metric"Generates income"≥2 offices paying flat fee for 3+ months; ≥25 funded wallets; ≥5 completed full-arch record sets; ≥1 patient-paid cross-border coordination; CAC per booked consult measured

PART IV — VERDICT

Feasible? Yes — but only in the refined form. As literally stated, no.

The stated MVP fails on three independent grounds — an illegal revenue mechanism, an unkeepable advertised guarantee, and a China pathway whose infrastructure and liability costs exceed the entire pilot's value. Any one of these would sink a financing conversation; together they would sink the pilot itself.

But none of the three flaws touches the core of the idea, and that is the encouraging part. The heart of this MVP — advertise the passport, fill the wallet, let the records travel, charge honestly for the service around them — survives every criticism fully intact. The repairs are substitutions, not amputations: flat service fees for referral fees, architectural portability for a warranty, records-first for tourism-first. The vision's breadth (Qingdao, the aftercare network, patient subscriptions) is preserved — it is sequenced, not deleted, which is exactly the discipline the master compendium already committed to: never confuse the long-term vision with current capability.

Conditions for proceeding (in order):

  1. Kill per-referral language everywhere; adopt the flat-fee service stack. (Blocking.)
  2. Rewrite the ad promise; add patient export as a launch feature. (Blocking.)
  3. Sign BAAs with all three offices; run ads under a neutral/cleared brand. (Blocking.)
  4. Confirm office commitments in writing — even a one-page pilot agreement. (Blocking; also answers the investor's first diligence question.)
  5. Demote Qingdao to Gate 1 (records-only, patient-paid). (Strongly advised.)
  6. Full-arch only in v1 ads. (Strongly advised.)

With those six conditions met, this is a genuinely good MVP: small enough to run by hand, real enough to produce revenue, and — uniquely among the options considered so far — it tests the actual long-term thesis (patient-carried records crossing provider and border lines) rather than a proxy for it.

Open items awaiting Josh/Jim's answers: office commitment status and Raymond's relationship to CareFirst; who fronts ad spend; whether any backing mechanism for the lifetime promise was intended; and whether CareFirst was meant to arrange overseas treatment or only carry records. Answers will be folded into v2 of this plan and the compendium's Open Questions Register.